The levels of tumor markers, including neuron-specific enolase (NSE), squamous cell carcinoma antigen (SCC), and cytokeratin-19 (CYFRA21-1), were higher in the non-MPR group, and the difference was statistically meaningful (Figures 3C–E, P < 0.05). The gene discussed is ENO2; the disease is neoplasm.